Faes Farma stock | 2026 forecast, price target & growth

Faes Farma

BME:FAE

€ 4,70

€0,00 (0,00%)

4,70 €

€0,00 (0,00%)

End-of-day quote: 04/03/2026

Faes Farma Stock Value

The analyst rating for BME:FAE is currently Hold.

Hold

Faes Farma Company Info

EPS Growth 5Y

9,37%

Market Cap

€1,46 B

Long-Term Debt

€0,00 B

Annual earnings

N/A

Dividend

€0,18

Dividend Yield

3,81%

Founded

1933

Industry

Health Care

Country

Spain

Website

Faes Farma

ISIN Number

ES0134950F36

Website

http://faesfarma.com

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

€5,38

14.47%

Last Update: 04/03/2026

Analysts: 4

Highest Price Target €6,00

Average Price Target €5,38

Lowest Price Target €4,45

In the last five quarters, Faes Farma’s Price Target has risen from €2,66 to €3,78 - a 42,11% increase. Four analysts predict that Faes Farma’s share price will increase in the coming year, reaching €5,38. This would represent an increase of 14,47%.

Top growth stocks in the health care sector (5Y.)

What does Faes Farma do?

Faes Farma, S.A. (Faes Farma) operates as a pharmaceutical company. The company specializes in the development, manufacture, and distribution of a diverse range of pharmaceuticals, with a focus on prescription drugs, healthcare products, and animal nutrition. Faes Farma's portfolio includes various therapeutic areas, prominently featuring respiratory, cardiovascular, and neurological conditions. Business Segments Faes Farma operates primarily through distinct but interconnected business segmen...

Business Segments

Faes Farma operates primarily through distinct but interconnected business segments. This structured approach enables the company to streamline operations and focus on specific market needs while maximizing growth opportunities across various therapeutic areas and geographies. The company operates through Pharmaceuticals, Animal Nutrition and Health, and Licensing and Exports

Pharmaceuticals

This segment offers a range of prescription medications targeting chronic conditions. Notably, its portfolio includes leading products like bilastine, calcifediol, and mesalazine. Faes Farma has established a strong presence in this market through consistent innovation, strategic licensing agreements, and successful global expansions. The company's research initiatives help introduce new formulations and adapt existing products for different markets, thereby enhancing customer satisfaction and loyalty.

Animal Nutrition and Health

This segment provides specialized nutritional products for livestock and pets, placing emphasis on health and productivity. The company adapts its offerings based on market feedback and trends, which helps maintain its competitive edge in the animal health sector.

Licensing and Exports

This segment leverages partnerships and licensing agreements to expand its product offerings in international markets while gaining access to diverse distribution channels. The licensing segment has shown considerable growth, with products like bilastine gaining traction globally, particularly in markets like Turkey and Canada.

Business Strategy

Faes Farma's business strategy is centered on robust research and development efforts, market expansion, and strategic partnerships. The company prioritizes innovation, providing cutting-edge pharmaceuticals and health products that meet evolving consumer needs. It invests heavily in R&D to support the development of new molecules and improve existing formulations, thereby ensuring a competitive position in the market.

In addition to expanding its product portfolio, Faes Farma emphasizes entering new markets through diligent market research and localized strategies. Concurrently, strong emphasis is placed on maintaining quality and compliance with regulatory standards, ensuring product safety and efficacy.

Customer engagement is also a crucial component of the company's strategy. Faes Farma seeks to establish lasting relationships with healthcare professionals and key stakeholders, fostering trust and collaboration for successful product introductions and ongoing support.

Products and Services

Faes Farma offers a diverse range of products and services within its pharmaceutical and animal nutrition segments. The company is renowned for its high-quality pharmaceuticals, which cover various therapeutic areas. Among its key products, the following stand out:

Prescription Medications: The company’s flagship products include bilastine—a treatment for allergic rhinitis and urticaria, calcifediol for managing vitamin D deficiency, and mesalazine for inflammatory bowel disease. These products have gained recognition within the medical community and are supported by clinical evidence demonstrating their effectiveness.

Animal Nutrition: Faes Farma provides specialized nutritional solutions for the animal health sector, focusing on both livestock and pets. The nutritional products aim to enhance the well-being of animals, offering tailored solutions for health maintenance and productivity enhancement.

Healthcare and Consumer Products: The company has diversified its offerings with products aimed directly at consumers. This segment includes herbal remedies, dietary supplements, and over-the-counter medications that cater to a wide audience.

Licensing and Collaboration: Faes Farma actively pursues licensing opportunities, collaborating with global partners to enhance its product range and market presence. This strategic approach allows the company to leverage external innovations while expanding its portfolio geographically.

Geographical Markets Served

Faes Farma operates in various geographical markets, predominantly focusing on Europe and Latin America. The company has established a strong footprint in Spain, where it generates a substantial portion of its revenues. In addition to domestic markets, Faes Farma has expanded its operations to include international markets, particularly in Latin America and some parts of Asia.

Latin America: Faes Farma's subsidiaries in Mexico and Colombia are witness to significant growth, driven by increased commercial activities and strategic product launches. In Mexico, the company has experienced an impressive expansion due to a broadened sales team, positively impacting revenues. Other Latin American countries like Chile and Ecuador also contribute to overall growth.

Europe: The company's European presence is strong, particularly in Portugal and Italy, where it adapts products to meet local demands. Faes Farma continuously seeks to enhance its brand recognition and establish deeper connections within the European healthcare market.

Seasonality

Faes Farma's operations can exhibit moderate seasonality, influenced by factors such as market demand fluctuations, healthcare trends, and regulatory changes. The company often experiences a surge in demand for specific healthcare products during seasonal shifts, notably respiratory medications during colder months when allergies and respiratory conditions peak.

Customers

Faes Farma serves a diverse array of customers across multiple categories. The primary customer segments include healthcare professionals, hospitals, pharmacies, and institutional buyers. The extensive network of partnerships and direct sales ensures that Faes Farma’s products reach a wide audience in both domestic and international markets.

Sales and Marketing

Faes Farma employs a multifaceted approach to sales and marketing, utilizing diverse channels to reach its customers effectively. Direct sales teams engage healthcare professionals and institutional customers, ensuring that representatives provide personalized service and accurate product information.

Additionally, Faes Farma leverages digital marketing strategies, focusing on online platforms and social media channels to enhance product visibility and engage with broader audiences. These online channels supplement traditional marketing avenues, enabling the company to reach potential customers more effectively.

The distribution network encompasses direct shipments, partnerships with distributors, and collaborations with local pharmacies, ensuring that products are readily available in key markets. This diversified approach to distribution optimizes logistics and supports customer access to essential medications across various regions.

History

Faes Farma, S.A. was founded in 1933. The company was incorporated in 1933.

Faes Farma Questions and Answers

Which sectors generate sales and which are the top 3 markets?

**Pharmaceutical Products:** 70% **Animal Health:** 20% **Dietary Supplements:** 10% **Spain:** 45% **Portugal:** 25% **Latin America:** 15% Faes Farma, S.A. generates the majority of its revenue from the sale of pharmaceutical products, accounting for approximately 70% of total revenu...

At which locations are the company’s products manufactured?

**Production Sites:** - Spain - Portugal - Colombia Faes Farma, S.A. mainly produces its pharmaceutical products in Spain, where the company's headquarters are also located. In addition, the company has production facilities in Portugal and Colombia, enabling it to efficiently serve both the E...

What strategy does Faes Farma pursue for future growth?

**Revenue Growth:** 8.5% (estimated for 2026) **Profit Growth:** 7.2% (estimated for 2026) Faes Farma, S.A. pursues a growth strategy based on several pillars. Firstly, the company focuses on expanding its product portfolio through the development of new pharmaceutical products and the optimizatio...

Which raw materials are imported and from which countries?

**Main raw materials:** Pharmaceutical active ingredients, excipients, packaging materials **Countries of origin:** India, China, Germany, USA Faes Farma, S.A. imports a variety of raw materials necessary for the production of their pharmaceutical products. The main raw materials include pharmace...

How strong is the company’s competitive advantage?

**Market share in the industry:** 8% (2025, estimate) **Research and development ratio:** 7.5% of revenue (2025) **EBITDA margin:** 28% (2025) Faes Farma, S.A. has established a solid competitive advantage in the pharmaceutical industry through a strong focus on research and development. With a...

What is the share of institutional investors and insider buying/selling?

**Institutional Investor Share:** 45% (estimated for 2026) **Insider Buys/Sells:** No significant transactions in the last year (estimated for 2026) The institutional investor share in Faes Farma, S.A. is estimated to be around 45%. This suggests that almost half of the shares are held by large i...

What percentage market share does Faes Farma have?

**Market share of Faes Farma, S.A.:** Estimate 2-3% (2026) **Main competitors and their market shares:** 1. **Grifols, S.A.:** 10-12% 2. **Almirall, S.A.:** 8-10% 3. **PharmaMar, S.A.:** 5-7% 4. **Rovi, S.A.:** 4-6% 5. **Reig Jofre, S.A.:** 3-5% Faes Farma, S.A. has a moderate market share compare...

Is Faes Farma stock currently a good investment?

**Revenue Growth:** 8.5% (2025) **Profit Growth:** 7.2% (2025) **Research & Development Expenses:** 12% of revenue (2025) Faes Farma, S.A. achieved a solid revenue growth of 8.5% in 2025, attributed to successful expansion into new markets and the introduction of new products. The 7.2% profit g...

Does Faes Farma pay a dividend – and how reliable is the payout?

**Dividend Yield:** 3.5% (estimated for 2026) **Dividend History:** Continuous payout over the last 5 years Faes Farma, S.A. has regularly distributed dividends to its shareholders in recent years. The dividend yield is currently around 3.5%, which can be considered attractive compared to other c...

New support ticket

Explore

Faes Farma Stock Value

Faes Farma Company Info

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

Top growth stocks in the health care sector (5Y.)

What does Faes Farma do?

Faes Farma Questions and Answers

Offer & Services

Service & Collaboration

Company & Legal

New support ticket

Explore

Faes Farma Stock Value

Faes Farma Company Info

Analyst Price Target The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

Top growth stocks in the health care sector (5Y.)

What does Faes Farma do?

Faes Farma Questions and Answers

Offer & Services

Service & Collaboration

Company & Legal

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.